Meetings & Symposiums

of the Chinese Antibody Society

Upcoming Meeting

Register today to reserve your seat

2023 annual meeting

2023 Annual Meeting - Submit Abstract Now

May 14, 2023 (US EDT)
Live In Person

Learn More & Register

Previous Meetings

CAS Members can sign in to view recordings

2022 annual meeting


AntibodyPlus: next generation antibody-based biologics

In the midst of the rapid development of novel antibody therapies and the “new normal” of the pandemic, the Chinese Antibody Society (CAS) will hold the 2022 Annual Conference in Boston on October 30, 2022 (Sunday). This will be the first in-person event of the Chinese Antibody Society since the pandemic started. The topic of the CAS 2022 Annual Conference is: “AntibodyPlus: next generation antibody-based biologics.”

2022 mAbTalk symposium


Emerging targets for immuno-oncology


2021 annual meeting


The next 100 antibodies to be approved by FDA: emerging antibody modalities and beyond

In our two half-day events, speakers from both industry and academia will share their insights in diverse topics of antibody-based therapeutics and discuss the new trend AntibodyPlusTM integration. This event is a perfect opportunity for the attendees to stay up to date on the most recent progress and challenges in antibody-based drug development.

2021 mAbTalk symposium


New Horizon of Antibody Drug Conjugate (ADC)

FREE Registration is now open for mAbTalks series in 2021 - “New Horizon of Antibody-Drug Conjugate (ADC)” virtual symposium. The symposium will be held online on May 23, 2021. In this half-day event, speakers from both industry and academia will share their insights in diverse topics of ADC-based therapeutics, including discovery & new techniques, clinical development.

2020 mAbTalk symposium


Revisit the Perspectives of Bispecific Antibodies under the COVID-19 Pandemic

Bispecific and multispecific antibody-based therapies are at the cutting-edge of therapeutic biologics development, and provide new opportunities to address unmet medical needs. In our one-day symposium, eight speakers from both industry and academia will share insights on all aspects of bispecific antibody-based therapeutic development, including novel targets and molecular formats, development of the lead candidate from discovery to clinics, CMC challenges and strategies, regulatory considerations, patent protection strategies, and COVID-19 related therapeutics.

This web app is a Python Django project independently coded (frontend+backend+deployment on AWS) by Xin Yu (Github, LinkedIn) in her volunteer capacity at the Chinese Antibody Society. Contents are maintained by CAS IT team. If you're interested in participating in the future development of this web app, please submit a volunteer application and request an interview with the IT team. We require a minimum of 2 years experience as a Django developer. © Chinese Antibody Society 2021. All Rights Reserved. Legal Disclaimer